ZYNEX INC 8-K

What Happened

• Zynex, Inc. and certain subsidiaries (the “Company Parties”) originally filed voluntary Chapter 11 petitions on December 15, 2025. On February 7, 2026 the Company filed a Third Amended Combined Disclosure Statement and Joint Plan of Reorganization [Docket No. 264], and on February 9, 2026 the Company began soliciting votes on the Plan. The Voting Deadline under the Plan is March 12, 2026.
• The Plan is consistent with a Restructuring Support Agreement (RSA) dated December 15, 2025, incorporates a global settlement among the Company Parties, the Ad Hoc Noteholder Group and the Official Committee of Unsecured Creditors, and provides for an equity transaction with a yet-to-be-determined “Plan Sponsor” through a parallel Sale Process.

Key Details

• Chapter 11 petition date: December 15, 2025; Third Amended Plan filed: February 7, 2026 (Docket No. 264); solicitation commenced: February 9, 2026; voting deadline: March 12, 2026.
• The Plan revises the scope of GUC Trust claims, causes of action and released parties and includes additional tax disclosures versus earlier drafts.
• The Plan contemplates a sale/ equity transaction with a Plan Sponsor and distribution of any Excess Sale Proceeds as provided in the Plan.
• Solicitation materials and court filings are available at https://dm.epiq11.com/Zynex.

Why It Matters

• For investors, this is a material bankruptcy reorganization: the Plan could result in a new equity structure via a Plan Sponsor sale and the likely cancellation or significant dilution of existing common stock. The Company explicitly warns shareholders they “will experience a significant loss” if the Restructuring Transactions are implemented.
• Trading in Zynex securities while these Chapter 11 cases proceed is highly speculative; market prices may not reflect any eventual recovery. Retail investors should review the Plan, related court filings and the voting materials, and monitor court approvals and confirmation timelines before making investment decisions.